A growing body of evidence has documented the dysregulation or overactivation of the complement system in HUS with increased plasmatic levels and intrarenal deposits of C3, C3a and C5b-9 in patients with active Stx-associated HUS [16,17]. The gene discussed is C3; the disease is hemolytic-uremic syndrome.